Genetics and Autoimmunity: Non-MHC Genes

The Autoimmune Diseases, Fourth Edition

Volumn , Issue , 2006, Pages 273-287

  Tomer, Yaron ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65249184241     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012595961-2/50024-X     Document Type: Chapter

References (156)

1. K. Agarwal, D.E. Jones, A.K. Daly, O.F. James, B. Vaidya, S. Pearce and M.F. Bassendine (2000) CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J. Hepatol. 32 538-541.
2. S. Ahmed, S.T. Bennett, S.J. Huxtable, J.A. Todd, D.R. Matthews and S.C. Gough (1999) INS VNTR allelic variation and dynamic insulin secretion in healthy adult non-diabetic Caucasian subjects. Diabet. Med. 16 910-917.
3. S. Ahmed, K.K.S. Ihara Kai Kanemitsu S., H. Nakashima, T. Otsuka, K. Tsuzaka, T. Takeuchi and T. Hara (2001) Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxf.) 40 662-667.
4. T. Akamizu, M.M. Sale, S.S. Rich, H. Hiratani, J.Y. Noh, N. Kanamoto, M. Saijo, Y. Miyamoto, Y. Saito, K. Nakao and D.W. Bowden (2000) Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 10 851-858.
5. E.M. Allen, M.C. Appel and L.E. Braverman (1987) Iodine-induced thyroiditis and hypothyroidism in the hemithyroidectomized BB/W rat. Endocrinology 121 481-485.
6. S.C. Bain, J.B. Prins, C.M. Hearne, N.R. Rodrigues, B.R. Rowe, L.E. Pritchard, R.J. Ritchie, J.R.S. Hall, D.E. Undlien, K.S. Ronningen, D.B. Dunger, A.H. Barnett and J.A. Todd (1992) Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nat. Genet. 2 212-215.
7. Y. Ban, T.F. Davies, D.A. Greenberg, A. Kissin, B. Marder, B. Murphy, E.S. Concepcion, R.B. Villanueva, G. Barbesino, V. Ling and Y. Tomer (2003) Analysis of the CTLA-4, CD28 and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 4 586-593.
8. Y. Ban, D.A. Greenberg, E. Concepcion, L. Skrabanek, R. Villanueva and Y. Tomer (2003) Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. USA 100 15119-15124.
9. Y. Ban, T. Tozaki, M. Taniyama, M. Tomita and Y. Ban (2004) Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin. Endocrinol. (Oxf.) 61 263-268.
10. J. Banchereau, F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset and S. Saeland (1994) The CD40 antigen and its ligand. Annu. Rev. Immunol. 12 881-922.
11. G. Barbesino, Y. Tomer, E.S. Concepcion, T.F. Davies and D. Greenberg (1998) Linkage analysis of candidate genes in autoimmune thyroid disease: 2. Selected gender-related genes and the X-chromosome. J. Clin. Endocrinol. Metab. 83 3290-3295.
12. K.G. Becker, R.M. Simon, J.E. Bailey-Wilson, B. Freidlin, W.E. Biddison, H.F. McFarland and J.M. Trent (1998) Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. USA 95 9979-9984.
13. A.B. Begovich, V.E. Carlton, L.A. Honigberg, S.J. Schrodi, A.P. Chokkalingam, H.C. Alexander, K.G. Ardlie, Q. Huang, A.M. Smith, J.M. Spoerke, M.T. Conn, M. Chang, S.Y. Chang, R.K. Saiki, J.J. Catanese, D.U. Leong, V.E. Garcia, L.B. McAllister, D.A. Jeffery, A.T. Lee, F. Batliwalla, E. Remmers, L.A. Criswell, M.F. Seldin, D.L. Kastner, C.I. Amos, J.J. Sninsky and P.K. Gregersen (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75 330-337.
14. G.I. Bell, S. Horita and J.H. Karam (1984) A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33 176-183.
15. S.T. Bennett, A.M. Lucassen, S.C.L. Gough, E.E. Powell, D.E. Undlien, D.E. Pritchard, M.E. Merriman, Y. Kawaguchi, M. Dronsfield, F. Pociot, J. Nerup, N. Bouzekri, A. Cambon-Thomsen, K.S. Ronningen, A.H. Barnett, S.C. Bain and J.A. Todd (1995) Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 9 284-292.
16. S.R. Block, J.B. Winfield, M.D. Lockshin, W.A. D'Angelo and C.L. Christian (1975) Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am. J. Med. 59 533-552.
17. A. Blomhoff, B.A. Lie, A.G. Myhre, E.H. Kemp, A.P. Weetman, H.E. Akselsen, E.S. Huseby and D.E. Undlien (2004) Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J. Clin. Endocrinol. Metab. 89 3474-3476.
18. N. Bottini, L. Musumeci, A. Alonso, S. Rahmouni, K. Nika, M. Rostamkhani, J. MacMurray, G.F. Meloni, P. Lucarelli, M. Pellecchia, G.S. Eisenbarth, D. Comings and T. Mustelin (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36 337-338.
19. H. Braley-Mullen, G.C. Sharp, B. Medling and H. Tang (1999) Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Autoimmun. 12 157-165.
20. T.H. Brix, K.O. Kyvik, K. Christensen and L. Hegedus (2001) Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab. 86 930-934.
21. M.C. Brunner, C.A. Chambers, F.K. Chan, J. Hanke, A. Winoto and J.P. Allison (1999) CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162 5813-5820.
22. C.L. Burek, W.H. Hoffman and N.R. Rose (1982) The presence of thyroid autoantibodies in children and adolescents with AITD and in their siblings and parents. Clin. Immunol. Immunopathol. 25 395-404.
23. C.L. Burek, N.R. Rose, K.E. Guire and W.H. Hoffman (1990) Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity 7 157-167.
24. L.C. Burkly (2001) CD40 pathway blockade as an approach to immunotherapy. Adv. Exp. Med. Biol. 489 135-152.
25. G. Carayanniotis, S.R. Masters and R.J. Noelle (1997) Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90 421-426.
26. C. Carey, C. Skosey, K.M. Pinnamaneni, C.P. Barsano and L.J. DeGroot (1980) Thyroid abnormalities in children of parents who have Graves' disease: possible pre-Graves' disease. Metabolism 29 369-376.
27. J. Cavanaugh (2001) International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am. J. Hum. Genet. 68 1165-1171.
28. J.H. Cho (2004) Advances in the genetics of inflammatory bowel disease. Curr. Gastroenterol. Rep. 6 467-473.
29. I.J. Chopra, D.H. Solomon, U. Chopra, E. Yodhihara, P.L. Tersaki and F. Smith (1977) Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8. J. Clin. Endocrinol. Metab. 45 45-54.
30. J.E. Collins, J.M. Heward, J. Carr-Smith, J. Daykin, J.A. Franklyn and S.C.L. Gough (2003) Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 88 5039-5042.
31. J.L. Davies, Y. Kawachi, S.T. Bennet, J.B. Copeman, H.J. Cordell, L.E. Pritchard, P.W. Reed, S.C.L. Gough, S.C. Jenkins, S.M. Palmer, K.M. Balfour, B.R. Rowe, M. Farrall, A.H. Barnett, S.C. Baln and J.A. Todd (1994) A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371 130-136.
32. K. Docherty (1992) 1992 R. D. Lawrence Lecture. The regulation of insulin gene expression. Diabet. Med. 9 792-798.
33. H. Donner, J. Braun, C. Seidl, H. Rau, R. Finke, M. Ventz, P.G. Walfish, K.H. Usadel and K. Badenhoop (1997) Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metab. 82 4130-4132.
34. H. Donner, H. Rau, P.G. Walfish, J. Braun, T. Siegmund, R. Finke, J. Herwig, K.H. Usadel and K. Badenhoop (1997) CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82 143-146.
35. F.H. Durie, T.M. Foy, S.R. Masters, J.D. Laman and R.J. Noelle (1994) The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15 406-411.
36. G.C. Ebers, D.E. Bulman, A.D. Sadovnick, D.W. Paty, S. Warren, W. Hader, T.J. Murray, T.P. Seland, P. Duquette and T. Grey (1986) A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315 1638-1642.
37. C. Eng (1996) Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N. Engl. J. Med. 335 943-951.
38. U.B. Ericsson, S.B. Christensen and J. Thorell (1985) A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin. Immunol. Immunopathol. 37 154-162.
39. L.A. Everett, B. Glaser, J.C. Beck, J.R. Idol, A. Buchs, M. Heyman, F. Adawi, E. Hazani, E. Nassir, A.D. Baxevanis, V.C. Sheffield and E.D. Green (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat. Genet. 17 411-422.
40. A.M. Glazier, J.H. Nadeau and T.J. Aitman (2002) Finding genes that underlie complex traits. Science 298 2345-2349.
41. P.K. Gregersen (2003) Teasing apart the complex genetics of human autoimmunity: lessons from rheumatoid arthritis. Clin. Immunol. 107 1-9.
42. D.M. Grennan, A. Parfitt, N. Manolios, Q. Huang, V. Hyland, H. Dunckley, T. Doran, P. Gatenby and C. Badcock (1997) Family and twin studies in systemic lupus erythematosus. Dis. Markers 13 93-98.
43. C.J. Grossman, G.A. Roselle and C.L. Mendenhall (1991) Sex steroid regulation of autoimmunity. J. Steroid Biochem. Mol. Biol. 40 649-659.
44. R. Hall and J.B. Stanbury (1967) Familial studies of autoimmune thyroiditis. Clin. Exp. Immunol. 2 719-725.
45. K. Hasegawa, F. Martin, G. Huang, D. Tumas, L. Diehl and A.C. Chan (2004) PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303 685-689.
46. L. Hashimoto, C. Habita, J.B. Beressl, M. Delepine, C. Besse, A. Cambon-Thomsen, I. Deschamps, J.I.D.S. Rotter J.I. aiDjouiah^S., M.R. James, P. Froguel, J. Weissenbach, G.M. Lathrop and C. Juiler (1994) Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371 161-164.
47. M. Hawa, R. Rowe, M.S. Lan, A.L. Notkins, P. Pozzilli, M.R. Christie and R.D. Leslie (1997) Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes 46 1270-1275.
48. A. Heltberg (1987) Twin studies in multiple sclerosis. Ital. J. Neurol. Sci. (Suppl. 6), 35-39.
49. M.C. Hochberg (1987) The application of genetic epidemiology to systemic lupus erythematosus. J. Rheumatol. 14 867-869.
50. P.M. Holopainen and J. Partanen (2001) Technical note: Linkage disequilibrium and disease-associated CTLA-4 gene polymorphisms. J. Immunol. 167 2457-2458.
51. D. Homann, A. Jahreis, T. Wolfe, A. Hughes, B. Coon, M.J. van Stipdonk, K.R. Prilliman, S.P. Schoenberger and M.G. von Herrath (2002) CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16 403-415.
52. F.A. Houston, V. Wilson, C.E. Jennings, C.J. Owen, P. Donaldson, P. Perros and S.H. Pearce (2004) Role of the CD40 locus in Graves' disease. Thyroid 14 506-509.
53. D. Huang, L. Liu, K. Noren, S.Q. Xia, J. Trifunovic, R. Pirskanen and A.K. Lefvert (1998) Genetic association of CTLA-4 to myasthenia gravis with thymoma. J. Neuroimmunol. 88 192-198.
54. D. Huang, R. Giscombe, Y. Zhou, R. Pirskanen and A.K. Lefvert (2000) Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J. Neuroimmunol. 105 69-77.
55. J.P. Hugot, P. Lauren-Puig, C. Gower-Rousseau, J.M. Olson, J.C. Lee, L. Beaugerie, I. Naom, J.-L. Dupas, A. Van Gossum, M. Orholm, C. Bonaiti-Pellie, J. Weissenbach, C.G. Mathew, J.E. Lennard-Jones, A. Cortot, J.-F. Colombel and G. Tomas (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379 821-823.
56. J.P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J.P. Cezard, J. Belaiche, S. Almer, C. Tysk, C.A. O'Morain and M. Gassull (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 599-603.
57. H. Imrie, B. Vaidya, P. Perros, W.F. Kelly, A.D. Toft, E.T. Young, P. Kendall-Taylor and S.H.S. Pearce (2001) Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J. Clin. Endocrinol. Metab. 86 626-630.
58. Inoue, N., Tamura, K., Kinouchi, Y., Fukuda, Y., Takahashi, S., Ogura, Y., Inohara, N., Nunez, G., Kishi, Y., Koike, Y., Shimosegawa, T., Shimoyama, T., and Hibi, T. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 123, 86–91.
59. P. Jarvinen and K. Aho (1994) Twin studies in rheumatic diseases. Semin. Arthritis Rheum. 24 19-28.
60. P. Jarvinen, J. Kaprio, R. Makitalo, M. Koskenvuo and K. Aho (1992) Systemic lupus erythematosus and related systemic diseases in a nation-wide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features. J. Intern. Med. 231 67-72.
61. J.C. Jaume, J. Guo, D.L. Pauls, M. Zakarija, J.M. McKenzie, J.A. Egeland, C.L. Burek, C.L. Burek, N.R. Rose, W.H. Hoffman, B. Rapoport and S.M. McLachlan (1999) Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic “fingerprints”. J. Clin. Endocrinol. Metab. 84 1424-1431.
62. D. Jawaheer, M.F. Seldin, C.I. Amos, W.V. Chen, R. Shigeta, J. Monteiro, M. Kern, L.A. Criswell, S. Albani, J.L. Nelson, D.O. Clegg, R. Pope, H.W. Schroeder Jr., S.L. Bridges Jr., D.S. Pisetsky, R. Ward, D.L. Kastner, R.L. Wilder, T. Pincus, L.F. Callahan, D. Flemming, M.H. Wener and P.K. Gregersen (2001) A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am. J. Hum. Genet. 68 927-936.
63. S.J. Kenealy, M.C. Babron, Y. Bradford, N. Schnetz-Boutaud, J.L. Haines, J.B. Rimmler, S. Schmidt, M.A. Pericak-Vance, L.F. Barcellos, R.R. Lincoln, J.R. Oksenberg, S.L. Hauser, M. Clanet, D. Brassat, G. Edan, J. Yaouanq, G. Semana, I. Cournu-Rebeix, O. Lyon-Caen and B. Fontaine (2004) A second-generation genomic screen for multiple sclerosis. Am. J. Hum. Genet. 75 1070-1078.
64. G.C. Kennedy, M.S. German and W.J. Rutter (1995) The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat. Genet. 9 293-298.
65. T.Y. Kim, Y.J. Park, J.K. Hwang, J.Y. Song, K.S. Park, B.Y. Cho and D.J. Park (2003) A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13 919-926.
66. E. Kinnunen, J. Juntunen, L. Ketonen, S. Koskimies, Y.T. Konttinen, T. Salmi, M. Koskenvuo and J. Kaprio (1988) Genetic susceptibility to multiple sclerosis. A co-twin study of a nationwide series. Arch. Neurol. 45 1108-1111.
67. K. Kotsa, P.F. Watson and A.P. Weetman (1997) A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin. Endocrinol. 46 551-554.
68. T. Kouki, Y. Sawai, C.A. Gardine, M.E. Fisfalen, M.L. Alegre and L.J. DeGroot (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J. Immunol. 165 6606-6611.
69. T. Kouki, C.A. Gardine, T. Yanagawa and L.J. DeGroot (2002) Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J. Endocrinol. Invest. 25 208-213.
70. O.P. Kristiansen, Z.M. Larsen and F. Pociot (2000) CTLA-4 in autoimmune diseases—a general susceptibility gene to autoimmunity? Genes Immun. 1 170-184.
71. R.C. Kuppers, H.S. Bresler, C. Lynne Burek, S.L. Gleason and N.R. Rose (1992) Immunodominant determinants of thyroglobulin associated with autoimmune thyroiditis. C.A. Bona, A.K. Kaushik (Eds) Molecular Immunobiology of Self-Reactivity New York: Marcel Dekker 247-284.
72. C. Kyogoku, C.D. Langefeld, W.A. Ortmann, A. Lee, S. Selby, V.E. Carlton, M. Chang, P. Ramos, E.C. Baechler, F.M. Batliwalla, J. Novitzke, A.H. Williams, C. Gillett, P. Rodine, R.R. Graham, K.G. Ardlie, P.M. Gaffney, K.L. Moser, M. Petri, A.B. Begovich, P.K. Gregersen and T.W. Behrens (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75 504-507.
73. K.O. Kyvik, A. Green and H. Beck-Nielsen (1995) Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ 311 913-917.
74. E. Lander and L. Kruglyak (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11 241-247.
75. L. Levin and Y. Tomer (2003) The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun. Rev. 2 377-386.
76. A. Ligers, N. Teleshova, T. Masterman, W.X. Huang and J. Hillert (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2 145-152.
77. A.M. Lucassen, C. Julier, J.P. Beressi, C. Boitard, P. Froguel, M. Lathrop and J.I. Bell (1993) Susceptibility to insulin-dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat. Genet. 4 305-310.
78. M.P. Marron, L.J. Raffel, H.J. Garchon, C.O. Jacob, M. SerranoRios, M.T. Martinez Larrad, W.P. Teng, Y. Park, Z.X. Zhang, D.R. Goldstein, Y.W. Tao, G. Beaurain, J.F. Bach, H.S. Huang, D.F. Luo, A. Zeidler, J.L. Rotter, M.C.K. Yang, T. Modilevsky, N.K. Maclaren and J.X. She (1997) Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet. 6 1275-1282.
79. M.P. Marron, A. Zeidler, L.J. Raffel, S.E. Eckenrode, J.J. Yang, D.I. Hopkins, H.J. Garchon, C.O. Jacob, M. Serrano-Rios, M.T. Martinez Larrad, Y. Park, J.F. Bach, J.I. Rotter, M.C. Yang and J.X. She (2000) Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes 49 492-499.
80. E. McCanlies, L.A. O'Leary, T.P. Foley, M.K. Kramer, J.P. Burke, A. Libman, J.S. Swan, A.R. Steenkiste, B.J. McCarthy, M. Trucco and J.S. Dorman (1998) Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J. Clin. Endocrinol. Metab. 83 1548-1551.
81. D.P. McGovern, D.A. van Heel, T. Ahmad and D.P. Jewell (2001) NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut 49 752-754.
82. L.J. Melton 3, P.J. Palumbo and C.P. Chu (1983) Incidence of diabetes mellitus by clinical type. Diabet. Care 6 75-86.
83. T.R. Merriman, H.J. Cordell, I.A. Eaves, P.A. Danoy, F. Coraddu, R. Barber, F. Cucca, S. Broadley, S. Sawcer, A. Compston, P. Wordsworth, J. Shatford, S. Laval, J. Jirholt, R. Holmdahl, A.N. Theofilopoulos, D.H. Kono, J. Tuomilehto, E. Tuomilehto-Wolf, R. Buzzetti, M.G. Marrosu, D.E. Undlien, K.S. Ronningen, C. Ionesco-Tirgoviste, J.P. Shield, F. Pociot, J. Nerup, C.O. Jacob, C. Polychronakos, S.C. Bain and J.A. Todd (2001) Suggestive evidence for association of human chromosome 18q12–q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes 50 184-194.
84. C.J. Mumford, N.W. Wood, H. Kellar-Wood, J.W. Thorpe, D.H. Miller and D.A. Compston (1994) The British Isles survey of multiple sclerosis in twins. Neurology 44 11-15.
85. L. Nistico, R. Buzzetti, L.E. Pritchard, B. Van der Auwera, C. Giovannini, E. Bosi, M.T. Larrad, M.S. Rios, C.C. Chow, C.S. Cockram, K. Jacobs, C. Mijovic, S.C. Bain, A.H. Barnett, C.L. Vandewalle, F. Schuit, F.K. Gorus, R. Tosi, P. Pozzilli and J.A. Todd (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 5 1075-1080.
86. R. Nithiyananthan, J.M. Heward, A. Allahabadia, J.A. Franklyn and S.C. Gough (2002) Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 12 3-6.
87. L.A. O'Neill (2004) How NOD-ing off leads to Crohn disease. Nat. Immunol. 5 776-778.
88. Y. Ogura, D.K. Bonen, N. Inohara, D.L. Nicolase, F.F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas and R.H. Duerr (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 603-606.
89. T. Paavonen (1994) Hormonal regulation of immune responses. Ann. Med. 26 255-258.
90. Y.J. Park, H.K. Chung, D.J. Park, W.B. Kim, S.W. Kim, J.J. Koh and B.Y. Cho (2000) Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10 453-459.
91. D.L. Pauls, M. Zakarija, J.M. McKenzie and J.A. Egeland (1993) Complex segregation analysis of antibodies to thyroid peroxidase in Old Order Amish families. Am. J. Med. Genet. 47 375-379.
92. S.H. Pearce, B. Vaidya, H. Imrie, P. Perros, W.F. Kelly, A.D. Toft, M.I. McCarthy, E.T. Young and P. Kendall-Taylor (1999) Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease [letter]. Am. J. Hum. Genet. 65 1462-1465.
93. D. Phillips, S. McLachlan, A. Stephenson, D. Roberts, S. Moffitt, D. McDonald, A. Ad'Hiah, A. Stratton, E. Young and F. Clark (1990) Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. J. Clin. Endocrinol. Metab. 70 742-746.
94. D.I.W. Phillips, L. Prentice, S.M. McLachlan, M. Upadhyaya, P.W. Lunt and B. Rees Smith (1991) Autosomal dominant inheritance of the tendency to develop thyroid autoantibodies. Exp. Clin. Endocrinol. 97 170-172.
95. F Pociot and M.F. McDermott (2002) Genetics of type 1 diabetes mellitus. Genes Immun. 3 235-249.
96. A. Puglise, M. Zeller, A. Fernandez Jr., L.J. Zalcberg, R.J. Bartlett, C. Ricordi, M. Pietropaolo, G.S. Eisenbarth, S.T. Bennett and D.D. Patel (1997) The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15 293-297.
97. E. Puxeddu and J.A. Fagin (2001) Genetic markers in thyroid neoplasia. Endocrinol. Metab. Clin. North. Am. 30 493-513.
98. M.J. Redondo, L. Yu, M. Hawa, T. Mackenzie, D.A. Pyke, G.S. Eisenbarth and R.D. Leslie (2001) Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44 354-362.
99. H. Reiser and M.J. Stadecker (1996) Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N. Engl. J. Med. 335 1369-1377.
100. A.S. Rigby, A.J. MacGregor and G. Thomson (1998) HLA haplotype sharing in rheumatoid arthritis sibships: risk estimates subdivided by proband genotype. Genet. Epidemiol. 15 403-418.
101. D.A. Ringold, J.T. Nicoloff, M. Kesler, H. Davis, A. Hamilton and T. Mack (2002) Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: The California twin study. Thyroid 12 647-653.
102. N. Risch (1987) Assessing the role of HLA-linked and unlinked determinants of disease. Am. J. Hum. Genet. 40 1-14.
103. N. Risch (1990) Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am. J. Hum. Genet. 46 229-241.
104. I.M. Roitt, P.N. Campbell and D. Doniach (1958) The nature of the thyroid autoantibodies present in patients with Hashimoto's thyroiditis (lymphadenoid goitre). Biochem. J. 69 248-254.
105. A.D. Sadovnick, H. Armstrong, G.P. Rice, D. Bulman, L. Hashimoto, D.W. Paty, S.A. Hashimoto, S. Warren, W. Hader and T.J. Murray (1993) A population-based study of multiple sclerosis in twins: update. Ann. Neurol. 33 281-285.
106. K. Sakai, S. Shirasawa, N Ishikawa, K Ito, H Tamai, K Kuma, T Akamizu, M Tanimura, K Furugaki, K Yamamoto and T Sasazuki (2001) Identification of susceptibility loci for autoimmune thyroid disease to 5q31–q33 and Hashimoto's thyroiditis to 8q23–q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum. Mol. Genet. 10 1379-1386.
107. M.M. Sale, T. Akamizu, T.D. Howard, T. Yokota, K. Nakao, T. Mori, H. Iwasaki, S.S. Rich, J.E. Jennings-Gee, M. Yamada and D.W. Bowden (1997) Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population. Proc. Assoc. Am. Physicians 109 453-461.
108. M. Schaub, S. Issazadeh, T.H. Stadlbauer, R. Peach, M.H. Sayegh and S.J. Khoury (1999) Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 96 158-166.
109. M.F. Seldin, C.I. Amos, R. Ward and P.K. Gregersen (1999) The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum. 42 1071-1079.
110. D. Smyth, J.D. Cooper, J.E. Collins, J.M. Heward, J.A. Franklyn, J.M. Howson, A. Vella, S. Nutland, H.E. Rance, L. Maier, B.J. Barratt, C. Guja, C. Ionescu-Tirgoviste, D.A. Savage, D.B. Dunger, B. Widmer, D.P. Strachan, S.M. Ring, N. Walker, D.G. Clayton, R.C. Twells, S.C. Gough and J.A. Todd (2004) Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53 3020-3023.
111. V. Stenszky, L. Kozma, C. Balazs, S. Rochlitz, J.C. Bear and N.R. Farid (1985) The genetics of Graves' disease: HLA and disease susceptibility. J. Clin. Endocrinol. Metab. 61 735-740.
112. J.J. Stewart (1998) The female X-inactivation mosaic in systemic lupus erythematosus. Immunol. Today 19 352-357.
113. K. Sugimura, K.D. Taylor, Y.C. Lin, T. Hang, D. Wang, Y.M. Tang, N. Fischel-Ghodsian, S.R. Targan, J.I. Rotter and H. Yang (2003) A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am. J. Hum. Genet. 72 509-518.
114. K.F. Tait, T. Marshall, J. Berman, J. Carr-Smith, B. Rowe, J.A. Todd, S.C. Bain, A.H. Barnett and S.C. Gough (2004) Clustering of autoimmune disease in parents of siblings from the Type 1 diabetes Warren repository. Diabet. Med. 21 358-362.
115. M. Takara, T. Kouki and L.J. DeGroot (2003) CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease. Thyroid 13 1083-1089.
116. H. Tamai, N. Ohsako, K. Takeno, O. Fukino, H. Takahashi, K. Kuma, L.F. Kumagai and S. Nagataki (1980) Changes in thyroid function in euthyroid subjects with family history of Graves' disease; a followup study of 69 patients. J. Clin. Endocrinol. Metab. 51 1123-1128.
117. H. Tamai, L.F. Kumagai and S. Nagataki (1986) Immunogenetics of Graves' disease. A.M. McGregor (Eds) Immunology of Endocrine Diseases Lancaster: MTP Press 123-141.
118. Y. Tomer (1997) Anti-thyroglobulin autoantibodies in autoimmune thyroid disease: cross-reactive or pathogenic? Clin. Immunol. Immunopathol. 82 3-11.
119. Y Tomer (2001) Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid 11 167-169.
120. Y. Tomer and T.F. Davies (1993) Infection, thyroid disease and autoimmunity. Endocr. Rev. 14 107-120.
121. Y. Tomer and T.F. Davies (2002) Genetic factors relating to the thyroid with emphasis on complex diseases. J.A.H. Waas, S.M. Shalet (Eds) Oxford Textbook of Endocrinology and Diabetes Oxford: Oxford University Press 358.
122. Y. Tomer and T.F. Davies (2003) Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr. Rev. 24 694-717.
123. Y. Tomer, G. Barbesino, D.A. Greenberg, E.S. Concepcion and T.F. Davies (1998) A new Graves disease-susceptibility locus maps to chromosome 20q11.2. Am. J. Hum. Genet. 63 1749-1756.
124. Y. Tomer, G. Barbesino, D.A. Greenberg, E.S. Concepcion and T.F. Davies (1999) Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: Evidence for genetic heterogeneity and gene interactions. J. Clin. Endocrinol. Metab. 84 4656-4664.
125. Y. Tomer, D.A. Greenberg, G. Barbesino, E.S. Concepcion and T.F. Davies (2001) CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J. Clin. Endocrinol. Metab. 86 1687-1693.
126. Y. Tomer, E. Concepcion and D.A. Greenberg (2002) A C/T single nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12 1129-1135.
127. Y. Tomer, D.A. Greenberg, E. Concepcion, Y. Ban and T.F. Davies (2002) Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 87 404-407.
128. Y. Tomer, Y. Ban, E. Concepcion, G. Barbesino, R. Villanueva, D.A. Greenberg and T.F. Davies (2003) Common and unique susceptibility loci in Graves and Hashimoto diseases: Results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet. 73 736-747.
129. Y. Tomer, T.F. Davies and D.A. Greenberg (2005) What is the contribution of a Kozak SNP in the CD40 gene to Graves' disease? Clin. Endocrinol. 62 258.
130. B.P. Tsao (2003) The genetics of human systemic lupus erythematosus. Trends Immunol. 24 595-602.
131. B.P. Tsao, J.M. Grossman, G. Riemekasten, N. Strong, J. Kalsi, D.J. Wallace, C.J. Chen, C.S. Lau, E.M. Ginzler, R. Goldstein, K.C. Kalunian, J.B. Harley, F.C. Arnett, B.H. Hahn and R.M. Cantor (2002) Familiality and co-occurrence of clinical features of systemic lupus erythematosus. Arthritis Rheum. 46 2678-2685.
132. W.M.G. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clark, J.G. Evans, E. Young, T. Bird and P.A. Smith (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxf.) 7 481-493.
133. H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D.B. Rainbow, K.M. Hunter, A.N. Smith, G. Di Genova, M.H. Herr, I. Dahlman, F. Payne, D. Smyth, C. Lowe, R.C. Twells, S. Howlett, B. Healy, S. Nutland, H.E. Rance, V. Everett, L.J. Smink, A.C. Lam, H.J. Cordell, N.M. Walker, C. Bordin, J. Hulme, C. Motzo, F. Cucca, J.F. Hess, M.L. Metzker, J. Rogers, S. Gregory, A. Allahabadia, R. Nithiyananthan, E. Tuomilehto-Wolf, J. Tuomilehto, P. Bingley, K.M. Gillespie, D.E. Undlien, K.S. Ronningen, C. Guja, C. Ionescu-Tirgoviste, D.A. Savage, A.P. Maxwell, D.J. Carson, C.C. Patterson, J.A. Franklyn, D.G. Clayton, L.B. Peterson, L.S. Wicker, J.A. Todd and S.C. Gough (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 506-511.
134. D.E. Undlien, S.T. Bennet, J.A. Todd, H.E. Akselsen, I. Ikaheimo, H. Reijonen, M. Knip, E. Thorsby and K.S. Ronningen (1995) Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes 44 620-625.
135. P. Vafiadis, S.T. Bennett, J.A. Todd, J. Nadeau, R. Grabs, C.G. Goodyer, S. Wickramasinghe, E. Colle and C. Polychronakos (1997) Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15 289-292.
136. B. Vaidya, H. Imrie, P. Perros, E.T. Young, W.F. Kelly, D. Carr, D.M. Large, A.D. Toft, M.I. McCarthy, P. Kendall-Taylor and S.H. Pearce (1999) The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum. Mol. Genet. 8 1195-1199.
137. B. Vaidya, H. Imrie, D.R. Geatch, P. Perros, S.G. Ball, P.H. Baylis, D. Carr, S.J. Hurel, R.A. James, W.F. Kelly, E.H. Kemp, E.T. Young, A.P. Weetman, P. Kendall-Taylor and S.H. Pearce (2000) Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 85 688-691.
138. B. Vaidya, H. Imrie, P. Perros, E.T. Young, W.F. Kelly, D. Carr, D.M. Large, A.D. Toft, P. Kendall-Taylor and S.H. Pearce (2000) Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am. J. Hum. Genet. 66 1710-1714.
139. B. Van der Auwera, H. Heimberg, A.F. Schrevens, C. Van Wayenberge, J. Flament and F.C. Schuit (1993) 5′ insulin gene polymorphism confers risks to IDDM independently of HLA class II susceptibility. Diabetes 42 851-854.
140. M. Van Griensven, E.C. Bergijk, J.J. Baelde, E. De Heer and J.A. Bruijn (1997) Differential effects of sex hormones on autoantibody production and proteinuria in chronic graft-versus-host disease-induced experimental lupus nephritis. Clin. Exp. Immunol. 107 254-260.
141. M.R. Velaga, V. Wilson, C.E. Jennings, C.J. Owen, S. Herington, P.T. Donaldson, S.G. Ball, R.A. James, R. Quinton, P. Perros and S.H. Pearce (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J. Clin. Endocrinol. Metab. 89 5862-5865.
142. R.B. Villanueva, A.M. Inzerillo, Y. Tomer, G. Barbesino, M. Meltzer, E.S. Concepcion, D.A. Greenberg, N. Maclaren, Z.S. Sun, D.M. Zhang, S. Tucci and T.F. Davies (2000) Limited genetic susceptibility to severe Graves' ophthalmopathy: No role for CTLA-4 and evidence for an environmental etiology. Thyroid 10 791-798.
143. R. Villanueva, D.A. Greenberg, T.F. Davies and Y. Tomer (2003) Sibling recurrence risk in autoimmune thyroid disease. Thyroid 13 761-764.
144. A.O. Vladutiu and N.R. Rose (1971) Autoimmune murine thyroiditis: relation to histocompatibiltiy (H-2) type. Science 174 1137-1139.
145. R. Volpe (1985) Autoimmune thyroid disease. R. Volpe (Eds) Autoimmunity and Endocrine Disease New York: Marcel Dekker 109-285.
146. T.J. Vyse and J.A. Todd (1996) Genetic analysis of autoimmune disease. Cell 85 311-318.
147. D.K. Wagener, J.M. Sacks, R.E. LaPorte and J.M. MacGregor (1982) The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM. Diabetes 31 136-144.
148. J.H. Warram, A.S. Krolewski, M.S. Gottlieb and C.R. Kahn (1984) Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N. Engl. J. Med. 311 149-152.
149. J.H. Warram, B.C. Martin and A.S. Krolewski (1991) Risk of IDDM in children of diabetic mothers decreases with increasing maternal age at pregnancy. Diabetes 40 1679-1684.
150. T. Watanabe, A. Kitani, P.J. Murray and W. Strober (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5 800-808.
151. J.P. Wood, M.A. Pani, K. Bieda, G. Meyer, K.H. Usadel and K. Badenhoop (2002) A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes. Eur. J. Immunogenet. 29 347-349.
152. Y. Xu, P. Graves, Y. Tomer and T. Davies (2002) CTLA-4 and auto-immune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4. Cell. Immunol. 215 133-140.
153. T. Yanagawa, Y. Hidaka, V. Guimaraes, M. Soliman and L.J. DeGroot (1995) CTLA-4 gene polymorphism associated with Graves' disease in a caucasian population. J. Clin. Endocrinol. Metab. 80 41-45.
154. T. Yanagawa, M. Taniyama, S. Enomoto, K. Gomi, H. Maruyama, Y. Ban and T. Saruta (1997) CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 7 843-846.
155. K. Zaletel, B. Krhin, S. Gaberscek, E. Pirnat and S. Hojker (2002) The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Thyroid 12 373-376.
156. X. Zhou, F.K. Tan, N. Wang, M. Xiong, S. Maghidman, J.D. Reveille, D.M. Milewicz, R. Chakraborty and F.C. Arnett (2003) Genomewide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthritis Rheum. 48 2585-2592.